ProFinder
Go Pro...

Lin Shen

Position not listed

Peking University · Beijing

Source

OpenAlex

Verification

Academic database source — not independently verified

Unverified

On file

Email
Not publicly verified
ORCID
0000-0002-8798-4756
Lab or group
Not publicly verified
Supervision
Not publicly verified
Last updated
2026-10-05

Research areas

Not available

Research interests

Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Esophageal Cancer Research and Treatment, HER2/EGFR in Cancer Research

Funding

Unknown

Not publicly verified. No grant, project, or funded-student record is stored.

Research timeline

Newest stored year: 2026. Topics on file: Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Esophageal Cancer Research and Treatment, HER2/EGFR in Cancer Research.

2026

  • A multifunctional biomimetic nanoplatform targeting mitochondrial dynamics and oxidative stress for heart failure therapy (2026)
  • Anti-cancer drug clinical research (2026)
  • Correction: Diagnostic discordance and treatment-associated change of PD-L1 and CLDN18.2 in gastric cancer: a real-world analysis of paired biopsy–resection samples (2026)
  • Efficacy and Safety of DVDMS ‐Photodynamic Therapy for Dysphagia in Advanced Esophageal Cancer: A Phase II Clinical Trial (2026)
  • First-Line Retlirafusp Alfa Plus Chemotherapy for Human Epidermal Growth Factor Receptor 2–Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Randomized, Double-Blind, Phase III Study (RELIGHT) (2026)

Papers linked only by a name match stay hidden.

Research match score

Sign in to see your personalized research match.

Target: Low priority

  • Research fit is not included until you sign in and save research interests.
  • Affiliation is not verified.
  • No email is stored.
  • A stored publication year is 2026.
  • Funding evidence is unknown, so it does not raise the priority.

Match, then draft, then copy. Mark Contacted on the tracker. Follow up only after you send it yourself.

Sign in